Search Orphan Drug Designations and Approvals
-
Generic Name: | satoreotide tetraxetan |
---|---|
Date Designated: | 09/24/2014 |
Orphan Designation: | Management of gastroenteropancreatic neuroendocrine tumors |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
SatoSea Oncology GmbH c/o LSP Services Deutschland GmbH Dachauer Str. 65 München 80335 Germany The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-